Search

everythinglearnresearchcommunity

for

Search:↓

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

CARASIL can cause different symptoms even with the same genetic mutation.

A new gene mutation may cause cyclic thrombocytopenia by affecting platelet production.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Scalp dermal papilla and fibrous sheath cells have different MMP expression than scalp dermal fibroblasts.

Activating PKM2 and Wnt/β-catenin signaling together can potentially enhance hair growth and could be a treatment for hair loss.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Both new medications and non-drug treatments can effectively manage migraines with fewer side effects.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Blocking a protein called prostaglandin D2 might help treat hair loss.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Botulinum Toxin Type A delivered through the skin may be a promising treatment for Frontal Fibrosing Alopecia.

Multiple pilomatrixoma may indicate Turner syndrome.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

CXCR2 in skin cells promotes tumor growth.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Recognizing minor skin lesions can help identify serious cancer syndromes.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.